Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-231,791
Closed -$5.15M 1281
2025
Q4
$5.15M Sell
231,791
-3,286
-1% -$82.9K 0.12% 164
2025
Q3
$5.99M Sell
235,077
-20,552
-8% -$507K 0.11% 177
2025
Q2
$6.2M Buy
255,629
+46,984
+23% +$1.1M 0.13% 164
2025
Q1
$5.29M Buy
208,645
+97,092
+87% +$2.54M 0.16% 135
2024
Q4
$2.96M Buy
111,553
+24,593
+28% +$667K 0.12% 171
2024
Q3
$2.52M Sell
86,960
-9,888
-10% -$288K 0.11% 203
2024
Q2
$2.71M Sell
96,848
-46,757
-33% -$1.29M 0.13% 166
2024
Q1
$3.98M Sell
143,605
-28,574
-17% -$793K 0.2% 114
2023
Q4
$4.96M Buy
172,179
+34,781
+25% +$1.05M 0.29% 81
2023
Q3
$4.56M Buy
137,398
+4,974
+4% +$176K 0.34% 66
2023
Q2
$4.86M Sell
132,424
-4,692
-3% -$183K 0.35% 64
2023
Q1
$5.59M Buy
137,116
+19,789
+17% +$855K 0.4% 53
2022
Q4
$6.01M Buy
117,327
+3,005
+3% +$144K 0.46% 42
2022
Q3
$5M Sell
114,322
-4,593
-4% -$223K 0.42% 47
2022
Q2
$6.24M Sell
118,915
-7,613
-6% -$388K 0.5% 37
2022
Q1
$6.55M Buy
126,528
+256
+0.2% +$13.3K 0.44% 42
2021
Q4
$7.46M Buy
126,272
+5,711
+5% +$283K 0.49% 35
2021
Q3
$5.18M Buy
120,561
+2,966
+3% +$131K 0.37% 46
2021
Q2
$4.61M Buy
117,595
+4,326
+4% +$168K 0.36% 60
2021
Q1
$4.1M Sell
113,269
-30,451
-21% -$1.08M 0.4% 53
2020
Q4
$5.29M Sell
143,720
-93,945
-40% -$3.45M 0.55% 33
2020
Q3
$8.28M Buy
237,665
+126,177
+113% +$4.42M 0.63% 25
2020
Q2
$3.46M Buy
+111,488
New +$3.79M 0.52% 47
2020
Q1
Sell
-99,739
Closed -$3.71M 384
2019
Q4
$3.71M Buy
+99,739
New +$3.55M 0.47% 47

Other funds holding PFE

J.W. Cole Advisors's PFE Position: Q1 2026 in Review

J.W. Cole Advisors sold out of Pfizer (PFE) in Q1 2026, closing a stake of 231,791 shares — an estimated $5.15M sold.

J.W. Cole Advisors first reported a position in PFE in Q4 2019 and held it in 24 quarters. The position peaked at $8.28M in Q3 2020. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • J.W. Cole Advisors reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • J.W. Cole Advisors sold 231,791 Pfizer shares in Q1 2026, an estimated $5.15M.
  • J.W. Cole Advisors first reported a position in Pfizer in Q4 2019 and held it in 24 quarters.
  • J.W. Cole Advisors's Pfizer position peaked at $8.28M in Q3 2020.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on J.W. Cole Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.